The Oxford Vaccine Group is researching a new way of surveying how well protected we are from vaccine preventable diseases by collecting blood samples from people who represent different groups across society.
The Oxford Vaccine Group is recruiting infants aged 4 – 7 months to a type 1 diabetes prevention trial. POInT (Primary Oral Insulin Trial) is recruiting infants who were screened for diabetes at birth through the INGR1D Study and have been found to be at high risk for developing diabetes.
Are you a parent or guardian of a child aged 0-5 years?
You may be interested in taking part in a study about vaccine attitudes.
This study is run by Oxford Vaccine Group, part of the University of Oxford.
What is the study about?
We will be holding focus groups (discussions) with small groups of parents of children aged 0-5 years.